On the public citation graph

Deciphering the mechanisms of action of progesterone in breast cancer

0 signed · 52 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 42 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1002/cam4.1353 (notice 2023-12-15).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2018.19323openalex-snapshot
Breast Cancer Treatment
inferredcites →https://doi.org/10.1002/cam4.1353openalex-snapshot
Retracted: Lnc RNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/ HMGA 2 axis in breast cancer
inferredcites →https://doi.org/10.1002/iub.1959openalex-snapshot
Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA‐146b‐5p mediated Wnt/β‐catenin signaling
inferredcites →https://doi.org/10.1002/jgm.3215openalex-snapshot
Microarray expression profiling of long noncoding RNAs in the progesterone‐treated lung cancer cells
inferredcites →https://doi.org/10.1002/ssu.2980070508openalex-snapshot
Primary treatment for breast cancer
inferredcites →https://doi.org/10.1007/s00432-006-0082-zopenalex-snapshot
Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient
inferredcites →https://doi.org/10.1007/s10549-018-4749-3openalex-snapshot
Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress
inferredcites →https://doi.org/10.1007/s13402-017-0330-zopenalex-snapshot
Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report
inferredcites →https://doi.org/10.1016/0140-6736(91)92927-topenalex-snapshot
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2023.05.008openalex-snapshot
Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)
inferredcites →https://doi.org/10.1016/j.breast.2022.08.010openalex-snapshot
Current and future burden of breast cancer: Global statistics for 2020 and 2040
inferredcites →https://doi.org/10.1016/j.celrep.2020.107753openalex-snapshot
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
inferredcites →https://doi.org/10.1016/j.ygeno.2022.110421openalex-snapshot
Estrogen distinctly regulates transcription and translation of lncRNAs and pseudogenes in breast cancer cells
inferredcites →https://doi.org/10.1038/nature14583openalex-snapshot
Progesterone receptor modulates ERα action in breast cancer
inferredcites →https://doi.org/10.1038/ncomms12791openalex-snapshot
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
inferredcites →https://doi.org/10.1038/s41388-021-01782-wopenalex-snapshot
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
inferredcites →https://doi.org/10.1038/s41416-020-0992-6openalex-snapshot
Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
inferredcites →https://doi.org/10.1038/s41419-021-04288-1openalex-snapshot
Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
inferredcites →https://doi.org/10.1038/s41419-021-04386-0openalex-snapshot
LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
inferredcites →https://doi.org/10.1038/s41467-019-13370-4openalex-snapshot
Author Correction: Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT
inferredcites →https://doi.org/10.1074/jbc.m111.292946openalex-snapshot
Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)
inferredcites →https://doi.org/10.1074/jbc.ra118.002894openalex-snapshot
Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and -negative breast cancer cells
inferredcites →https://doi.org/10.1080/15384047.2017.1373216openalex-snapshot
miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells
inferredcites →https://doi.org/10.1126/scitranslmed.abo5959openalex-snapshot
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer
inferredcites →https://doi.org/10.1128/mcb.01398-09openalex-snapshot
Cyclin D1 Enhances the Response to Estrogen and Progesterone by Regulating Progesterone Receptor Expression
inferredcites →https://doi.org/10.1155/2022/9613095openalex-snapshot
Downregulation of HULC Induces Ferroptosis in Hepatocellular Carcinoma via Targeting of the miR‐3200‐5p/ATF4 Axis
inferredcites →https://doi.org/10.1159/000353099openalex-snapshot
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
inferredcites →https://doi.org/10.1177/1758835920940946openalex-snapshot
The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
inferredcites →https://doi.org/10.1186/s12943-018-0830-0openalex-snapshot
Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer
inferredcites →https://doi.org/10.1186/s13058-022-01597-xopenalex-snapshot
Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer
inferredcites →https://doi.org/10.1200/jco.2005.09.004openalex-snapshot
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
inferredcites →https://doi.org/10.1200/jco.2010.33.0738openalex-snapshot
Single-Injection Depot Progesterone Before Surgery and Survival in Women With Operable Breast Cancer: A Randomized Controlled Trial
inferredcites →https://doi.org/10.1210/me.2013-1196openalex-snapshot
Progesterone Receptor–Cyclin D1 Complexes Induce Cell Cycle–Dependent Transcriptional Programs in Breast Cancer Cells
inferredcites →https://doi.org/10.1259/bjr.20211033openalex-snapshot
Understanding breast cancer as a global health concern
inferredcites →https://doi.org/10.1371/journal.pone.0087268openalex-snapshot
Global Gene Expression Analysis Reveals a Link between NDRG1 and Vesicle Transport
inferredcites →https://doi.org/10.1530/jme-20-0104openalex-snapshot
90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future
inferredcites →https://doi.org/10.21037/atm-22-795openalex-snapshot
Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer
inferredcites →https://doi.org/10.2147/ott.s143787openalex-snapshot
HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a
inferredcites →https://doi.org/10.26355/eurrev_201804_14726openalex-snapshot
LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer.
inferredcites →https://doi.org/10.26355/eurrev_202007_22274openalex-snapshot
LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
inferredcites →https://doi.org/10.3233/cbm-190703openalex-snapshot
DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling
inferredcites →https://doi.org/10.3892/ol.2021.13086openalex-snapshot
lncRNA DSCAM‑AS1 facilitates the progression of endometrial cancer via miR‑136‑5p

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5192830openalex-extracted
In Silico Therapeutic Strategy for Targeting Hormone Receptors and Her2-Low Tnbc: A Molecular Dynamics and Admet-Based Evaluation
inferred← citeshttps://doi.org/10.1002/jbt.70670openalex-snapshot
Cubebin Niosomal Suspension Attenuates DMBA‐Induced Breast Cancer Through the Involvement of Estrogen and Progesterone Receptors and Oxidative/Inflammatory/CA 15‐3 Tumor Marker
inferred← citeshttps://doi.org/10.1007/s12672-025-03764-wopenalex-snapshot
Decoding breast cancer: insights into molecular pathways & therapeutic approaches
inferred← citeshttps://doi.org/10.1007/s13596-024-00781-yopenalex-snapshot
Ethanol extract of black shallot (Allium ascalonicum Linnaeus) for breast cancer prevention: evidence from a DMBA-induced mouse model
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.03.018openalex-snapshot
Computational biology approaches for drug repurposing
inferred← citeshttps://doi.org/10.1016/j.ncrna.2026.03.001openalex-snapshot
Targeting lncRNA DSCAM-AS1 for disease diagnosis and therapy
inferred← citeshttps://doi.org/10.1016/j.steroids.2024.109474openalex-snapshot
Antitumor progestins activity: Cytostatic effect and immune response
inferred← citeshttps://doi.org/10.1080/07853890.2025.2570794openalex-snapshot
Progestins - a review of clinical application in gynecology
inferred← citeshttps://doi.org/10.1186/s13058-025-02157-9openalex-snapshot
Survival analysis of adjuvant endocrine therapy in HER2 positive early breast cancer patients with low ER positivity
inferred← citeshttps://doi.org/10.3390/cimb48010108openalex-snapshot
Comprehensive Transcriptomic Analysis and Biomarker Prioritization of Hydroxyprogesterone in Breast Cancer
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.